CD44 and its role in inflammation and inflammatory diseases

Inflammation and Allergy - Drug Targets

Volumn 8, Issue 3, 2009, Pages 208-220

  Johnson, Pauline ^a   Ruffell, Brian ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

CD44; Hyaluronan; Inflammation; Inflammatory diseases

Indexed keywords

ANTIASTHMATIC AGENT; ANTIINFLAMMATORY AGENT; HERMES ANTIGEN; HYALURONIC ACID; HYALURONIDASE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY IM7; MONOCLONAL ANTIBODY KM201; PEPTIDE PEP 1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ALLERGIC REACTION; ANAPHYLACTIC SHOCK; ANTIGEN BINDING CELL; ARTHRITIS; ASTHMA; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; CELL DEATH; CELL TRANSPORT; CHRONIC INFLAMMATION; DIABETES MELLITUS; DRUG MECHANISM; DRUG SCREENING; DRUG TARGETING; INFLAMMATION; INFLAMMATORY DISEASE; ISCHEMIA; JOINT SWELLING; KNEE OSTEOARTHRITIS; LEUKOCYTE; LIVER INJURY; LUNG INJURY; MACROPHAGE; MULTIPLE SCLEROSIS; NEUTROPHIL; NONHUMAN; PROTEIN BINDING; REVIEW; RHEUMATOID ARTHRITIS; SEPSIS; T LYMPHOCYTE; TISSUE INJURY; UVEITIS; UVEORETINITIS; ANIMAL; CELL ADHESION; ENDOTHELIUM CELL; HUMAN; HYPERSENSITIVITY; IMMUNOLOGY; METABOLISM; MOUSE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD44; AUTOIMMUNE DISEASES; CELL ADHESION; ENDOTHELIAL CELLS; HUMANS; HYALURONIC ACID; HYPERSENSITIVITY; INFLAMMATION; MACROPHAGES; MICE; NEUTROPHILS; T-LYMPHOCYTES;

EID: 70349325630     PISSN: 18715281     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152809788680994     Document Type: Review

References (128)

1. Medzhitov, R. Origin and physiological roles of inflammation. Nature, 2008, 454, 428-35.
2. Lohr, J.; Knoechel, B.; Nagabhushanam, V.; Abbas, A.K. T-cell tolerance and autoimmunity to systemic and tissue-restricted self-antigens. Immunol. Rev., 2005, 204, 116-27.
3. Rock, K.L.; Kono, H. The inflammatory response to cell death. Annu. Rev. Pathol., 2008, 3, 99-126.
4. Sriskandan, S.; Altmann, D.M. The immunology of sepsis. J. Pathol., 2008, 214, 211-23.
5. Ley, K.; Laudanna, C.; Cybulsky, M.I.; Nourshargh, S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol., 2007, 7, 678-89.
6. Miyasaka, M.; Tanaka, T. Lymphocyte trafficking across high endothelial venules: dogmas and enigmas. Nat. Rev. Immunol., 2004, 4, 360-70.
7. Springer, T.A. Traffic signals for lymphocyte recirculation and leukocyte emigration. Cell, 1994, 76, 301-14.
8. Petri, B.; Phillipson, M.; Kubes, P. The physiology of leukocyte recruitment: an in vivo perspective. J. Immunol., 2008, 180, 6439-46.
9. Jaeschke, H.; Smith, C.W. Cell adhesion and migration. III. Leukocyte adhesion and transmigration in the liver vasculature. Am. J. Physiol., 1997, 273, G1169-73.
10. Wong, J.; Johnston, B.; Lee, S.S.; Bullard, D.C.; Smith, C.W.; Beaudet, A.L.; Kubes, P.A minimal role for selectins in the recruitment of leukocytes into the inflamed liver microvasculature. J. Clin. Invest., 1997, 99, 2782-90.
11. Serhan, C.N.; Savill, J. Resolution of inflammation: the beginning programs the end. Nat. Immunol., 2005, 6, 1191-7.
12. Chen, W.Y.; Abatangelo, G. Functions of hyaluronan in wound repair. Wound Repair Regen., 1999, 7, 79-89.
13. Jiang, D.; Liang, J.; Noble, P.W. Hyaluronan in tissue injury and repair. Annu. Rev. Cell Dev. Biol., 2007, 23, 435-61.
14. Rittirsch, D.; Flierl, M.A.; Ward, P.A. Harmful molecular mechanisms in sepsis. Nat. Rev. Immunol., 2008, 8, 776-87.
15. Galli, S.J.; Tsai, M.; Piliponsky, A.M. The development of allergic inflammation. Nature, 2008, 454, 445-54.
16. Holgate, S.T.; Polosa, R. Treatment strategies for allergy and asthma. Nat. Rev. Immunol., 2008, 8, 218-30.
17. Toole, B.P. Hyaluronan: from extracellular glue to pericellular cue. Nat. Rev. Cancer, 2004, 4, 528-39.
18. Stern, R.; Asari, A.A.; Sugahara, K.N. Hyaluronan fragments: an information-rich system. Eur. J. Cell Biol., 2006, 85, 699-715.
19. Camenisch, T.D.; Spicer, A.P.; Brehm-Gibson, T.; Biesterfeldt, J.; Augustine, M.L.; Calabro, A., Jr.; Kubalak, S.; Klewer, S.E.; McDonald, J.A. Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. J. Clin. Invest., 2000, 106, 349-60.
20. DeGrendele, H.C.; Estess, P.; Picker, L.J.; Siegelman, M.H. CD44 and its ligand hyaluronate mediate rolling under physiologic flow - a novel lymphocyte-endothelial cell primary adhesion pathway. J. Exp. Med., 1996, 183, 1119-30.
21. de la Motte, C.A.; Hascall, V.C.; Drazba, J.; Bandyopadhyay, S.K.; Strong, SA. Mononuclear leukocytes bind to specific hyaluronan structures on colon mucosal smooth muscle cells treated with polyinosinic acid:polycytidylic acid: inter-alpha-trypsin inhibitor is crucial to structure and function. Am. J. Pathol., 2003, 163, 121-33.
22. Gallagher, J.T.; Spooncer, E.; Dexter, T.M. Role of the cellular matrix in haemopoiesis. I. Synthesis of glycosaminoglycans by mouse bone marrow cell cultures. J. Cell Sci., 1983, 63, 155-71.
23. Fraser, J.R.; Laurent, T.C.; Laurent, U.B. Hyaluronan: its nature, distribution, functions and turnover. J. Intern. Med., 1997, 242, 27-33.
24. Laurent, T.C.; Fraser, J.R. E. Hyaluronan. FASEB J., 1992, 6, 2397-404.
25. Jameson, J.M.; Cauvi, G.; Sharp, L.L.; Witherden, D.A.; Havran, W.L. Gammadelta T cell-induced hyaluronan production by epithelial cells regulates inflammation. J. Exp. Med., 2005, 201, 1269-79.
26. Rooney, P.; Kumar, S.; Ponting, J.; Wang, M. The role of hyaluronan in tumour neovascularization. Int. J. Cancer, 1995, 60, 632-6.
27. Trochon, V.; Mabilat, C.; Bertrand, P.; Legrand, Y.; Smadja-Joffe, F.; Soria, C.; Delpech, B.; Lu, H. Evidence of involvement of CD44 in endothelial cell proliferation, migration and angiogenesis in vitro. Int. J. Cancer, 1996, 66, 664-68.
28. West, D.C.; Kumar, S. The effect of hyaluronate and its oligosaccharides on endothelial cell proliferation and monolayer integrity. Exp. Cell Res., 1989, 183, 179-96.
29. Cuff, C.A.; Kothapalli, D.; Azonobi, I.; Chun, S.; Zhang, Y.; Belkin, R.; Yeh, C.; Secreto, A.; Assoian, R.K.; Rader, D.J.; Pure, E. The adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activation. J. Clin. Invest., 2001, 108, 1031-40.
30. Stern, R. Hyaluronan catabolism: a new metabolic pathway. Eur. J. Cell Biol., 2004, 83, 317-25.
31. Harada, H.; Takahashi, M. CD44-dependent intracellular and extracellular catabolism of hyaluronic acid by hyaluronidase-1 and -2. J. Biol. Chem., 2006,
32. Culty, M.; Nguyen, H.A.; Underhill, C.B. The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan. J. Cell Biol., 1992, 116, 1055-62.
33. Underhill, C.B.; Nguyen, H.A.; Shizari, M.; Culty, M. CD44 positive macrophages take up hyaluronan during lung development. Dev. Biol., 1993, 155, 324-36.
34. Toole, B.P. Hyaluronan and its binding proteins, the hyaladherins. Curr. Opin. Cell Biol., 1990, 2, 839-44.
35. Milner, C.M.; Day, A.J. TSG-6: a multifunctional protein associated with inflammation. J. Cell Sci., 2003, 116, 1863-73.
36. Huang, L.; Yoneda, M.; Kimata, K. A serum-derived hyaluronan-associated protein (SHAP) is the heavy chain of the inter alpha-trypsin inhibitor. J. Biol. Chem., 1993, 268, 26725-30.
37. Zhuo, L.; Kanamori, A.; Kannagi, R.; Itano, N.; Wu, J.; Hamaguchi, M.; Ishiguro, N.; Kimata, K. SHAP potentiates the CD44-mediated leukocyte adhesion to the hyaluronan substratum. J. Biol. Chem., 2006, 281, 20303-14.
38. Jackson, D.G. Biology of the lymphatic marker LYVE-1 and applications in research into lymphatic trafficking and lymphangiogenesis. Apmis., 2004, 112, 526-38.
39. Johnson, P.; Maiti, A.; Brown, K.L.; Li, R. A role for the cell adhesion molecule CD44 and sulfation in leukocyte-endothelial cell adhesion during an inflammatory response? Biochem. Pharm., 2000, 59, 455-65.
40. Lesley, J.; Hyman, R. CD44 structure and function. Front. Biosci., 1998, 3, 616-30.
41. Lesley, J.; Hyman, R.; English, N.; Catterall, J.B.; Turner, G.A. CD44 in inflammation and metastasis. Glycoconj. J., 1997, 14, 611-22.
42. Ponta, H.; Sherman, L.; Herrlich, P.A. CD44: from adhesion molecules to signalling regulators. Nat. Rev. Mol. Cell. Biol., 2003, 4, 33-45.
43. Pure, E.; Cuff, C.A. A crucial role for CD44 in inflammation. Trends Mol. Med., 2001, 7, 213-21.
44. Ruffell, B.; Johnson, P. The regulation and function of hyaluronan binding by CD44 in the immune system. Glycoforum: Science of hyaluronan today. http://www.glycoforum.gr.jp/science/hyaluronan/HA32/ HA32E.html, 2009.
45. Sackstein, R. The bone marrow is akin to skin: HCELL and the biology of hematopoietic stem cell homing. J. Investig. Dermatol. Symp. Proc., 2004, 9, 215-23.
46. Katoh, S.; Miyagi, T.; Taniguchi, H.; Matsubara, Y.; Kadota, J.; Tominaga, A.; Kincade, P.W.; Matsukura, S.; Kohno, S. Cutting edge: An inducible sialidase regulates the hyaluronic acid binding ability of CD44-bearing human monocytes. J. Immunol., 1999, 162, 5058-61.
47. English, N.M.; Lesley, J.F.; Hyman, R. Site-specific de-N-glycosylation of CD44 can activate hyaluronan binding, and CD44 activation states show distinct threshold densities for hyaluronan binding. Cancer Res., 1998, 58, 3736-42.
48. Skelton, T.P.; Zeng, C.X.; Nocks, A.; Stamenkovic, I. Glycosylation provides both stimulatory and inhibitory effects on cell surface and soluble CD44 binding to hyaluronan. J. Cell Biol., 1998, 140, 431-46.
49. Ruffell, B.; Johnson, P. Chondroitin sulfate addition to CD44H negatively regulates hyaluronan binding. Biochem. Biophys. Res. Commun., 2005, 334, 306-12.
50. Lesley, J.; Howes, N.; Perschl, A.; Hyman, R. Hyaluronan binding function of CD44 is transiently activated on T cells during an in vivo immune response. J. Exp. Med., 1994, 180, 383-7.
51. Levesque, M.C.; Haynes, B.F. Cytokine induction of the ability of human monocyte CD44 to bind hyaluronan is mediated primarily by TNF-alpha and is inhibited by IL-4 and IL-13. J. Immunol., 1997, 159, 6184-94.
52. Brown, K.L.; Maiti, A.; Johnson, P. Role of sulfation in CD44-mediated hyaluronan binding induced by inflammatory mediators in human CD14+ peripheral blood monocytes. J. Immunol., 2001, 167, 5367-74.
53. Schmits, R.; Filmus, J.; Gerwin, N.; Senaldi, G.; Kiefer, F.; Kundig, T.; Wakeham, A.; Shahinian, A.; Catzavelos, C.; Rak, J.; Furlonger, C.; Zakarian, A.; Simard, J.J.L.; Ohashi, P.S.; Paige, C.J.; Gutierrezramos, J.C.; Mak, T.W. CD44 regulates hematopoietic progenitor distribution, granuloma formation and tumorigenicity. Blood, 1997, 90, 2217-33.
54. Siegelman, M.H.; DeGrendele, H.C.; Estess, P. Activation and interaction of CD44 and hyaluronan in immunological systems. J. Leukoc. Biol., 1999, 66, 315-21.
55. Naor, D.; Nedvetzki, S.; Walmsley, M.; Yayon, A.; Turley, E.A.; Golan, I.; Caspi, D.; Sebban, L.E.; Zick, Y.; Garin, T.; Karussis, D.; Assayag-Asherie, N.; Raz, I.; Weiss, L.; Slavin, S. CD44 involvement in autoimmune inflammations: the lesson to be learned from CD44-targeting by antibody or from knockout mice. Ann. N. Y. Acad. Sci., 2007, 1110, 233-47.
56. Hutas, G.; Bajnok, E.; Gal, I.; Finnegan, A.; Glant, T.T.; Mikecz, K. CD44-specific antibody treatment and CD44 deficiency exert distinct effects on leukocyte recruitment in experimental arthritis. Blood, 2008, 112 (13), 4999-5006
57. Dimitroff, C.J.; Lee, J.Y.; Fuhlbrigge, R.C.; Sackstein, R.A distinct glycoform of CD44 is an L-selectin ligand on human hematopoietic cells. Proc. Natl. Acad. Sci. USA, 2000, 97, 13841-46.
58. Dimitroff, C.J.; Lee, J.Y.; Rafii, S.; Fuhlbrigge, R.C.; Sackstein, R. CD44 is a major E-selectin ligand on human hematopoietic progenitor cells. J. Cell Biol., 2001, 153, 1277-86.
59. Katayama, Y.; Hidalgo, A.; Chang, J.; Peired, A.; Frenette, P.S. CD44 is a physiological E-selectin ligand on neutrophils. J. Exp. Med., 2005, 201, 1183-9.
60. Nedvetzki, S.; Gonen, E.; Assayag, N.; Reich, R.; Williams, R.O.; Thurmond, R.L.; Huang, J.F.; Neudecker, B.A.; Wang, F.S.; Turley, E.A.; Naor, D. RHAMM, a receptor for hyaluronan-mediated motility, compensates for CD44 in inflamed CD44-knockout mice: a different interpretation of redundancy. Proc. Natl. Acad. Sci. USA, 2004, 101, 18081-6.
61. DeGrendele, H.C.; Estess, P.; Siegelman, M.H. Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science, 1997, 278, 672-75.
62. Khan, A.I.; Kerfoot, S.M.; Heit, B.; Liu, L.; Andonegui, G.; Ruffell, B.; Johnson, P.; Kubes, P. Role of CD44 and hyaluronan in neutrophil recruitment. J. Immunol., 2004, 173, 7594-601.
63. Teder, P.; Vandivier, R.W.; Jiang, D.; Liang, J.; Cohn, L.; Pure, E.; Henson, P.M.; Noble, P. W. Resolution of lung inflammation by CD44. Science, 2002, 296, 155-8.
64. Clark, R.A.; Alon, R.; Springer, T.A. CD44 and hyaluronan-dependent rolling interactions of lymphocytes on tonsillar stroma. J. Cell Biol., 1996, 134, 1075-87.
65. DeGrendele, H.C.; Kosfiszer, M.; Estess, P.; Siegelman, M.H. CD44 activation and associated primary adhesion is inducible via T cell receptor stimulation. J. Immunol., 1997, 159, 2549-53.
66. Siegelman, M.H.; Stanescu, D.; Estess, P. The CD44-initiated pathway of T-cell extravasation uses VLA-4 but not LFA-1 for firm adhesion. J. Clin. Invest., 2000, 105, 683-91.
67. Nandi, A.; Estess, P.; Siegelman, M. Bimolecular complex between rolling and firm adhesion receptors required for cell arrest; CD44 association with VLA-4 in T cell extravasation. Immunity, 2004, 20, 455-65.
68. Bonder, C.S.; Clark, S.R.; Norman, M.U.; Johnson, P.; Kubes, P. Use of CD44 by CD4+ Th1 and Th2 lymphocytes to roll and adhere. Blood, 2006, 107, 4798-806.
69. Mohamadzadeh, M.; DeGrendele, H.; Arizpe, H.; Estess, P.; Siegelman, M. Proinflammatory stimuli regulate endothelial hyaluronan expression and CD44/HA-dependent primary adhesion. J. Clin. Invest., 1998, 101, 97-108.
70. Maiti, A.; Maki, G.; Johnson, P. TNF-α induction of CD44-mediated leukocyte adhesion by sulfation. Science, 1998, 282, 941-43.
71. Nandi, A.; Estess, P.; Siegelman, M.H. Hyaluronan anchoring and regulation on the surface of vascular endothelial cells is mediated through the functionally active form of CD44. J. Biol. Chem., 2000, 275, 14939-48.
72. Zhao, L.; Lee, E.; Zukas, A.M.; Middleton, M.K.; Kinder, M.; Acharya, P.S.; Hall, J.A.; Rader, D.J.; Pure, E. CD44 expressed on both bone marrow-derived and non-bone marrow-derived cells promotes atherogenesis in ApoE-deficient mice. Arterioscler. Thromb. Vasc. Biol., 2008, 28, 1283-9.
73. Tanaka, Y.; Adams, D.H.; Shaw, S. Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes. Immunol. Today, 1993, 14, 111-5.
74. Tanaka, Y.; Adams, D.H.; Hubscher, S.; Hirano, H.; Siebenlist, U.; Shaw, S.T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1 beta. Nature, 1993, 361, 79-82.
75. Wu, Y.J.; Lapierre, D.; Wu, J.; Yee, A.J.; Yang, B.B. The interaction of versican with its binding partners. Cell Res., 2005, 15, 483-94.
76. McDonald, B.; McAvoy, E.F.; Lam, F.; Gill, V.; de la Motte, C.; Savani, R.C.; Kubes, P. Interaction of CD44 and hyaluronan is the dominant mechanism for neutrophil sequestration in inflamed liver sinusoids. J. Exp. Med., 2008, 205, 915-27.
77. Szanto, S.; Gal, I.; Gonda, A.; Glant, T.T.; Mikecz, K. Expression of L-selectin, but not CD44, is required for early neutrophil extravasation in antigen-induced arthritis. J. Immunol., 2004, 172, 6723-34.
78. Alstergren, P.; Zhu, B.; Glougauer, M.; Mak, T.W.; Ellen, R.P.; Sodek, J. Polarization and directed migration of murine neutrophils is dependent on cell surface expression of CD44. Cell Immunol., 2004, 231, 146-57.
79. Kipnis, A.; Basaraba, R.J.; Turner, J.; Orme, I.M. Increased neutrophil influx but no impairment of protective immunity to tuberculosis in mice lacking the CD44 molecule. J. Leukoc. Biol., 2003, 74, 992-7.
80. Wang, Q.; Teder, P.; Judd, N.P.; Noble, P.W.; Doerschuk, C.M. CD44 deficiency leads to enhanced neutrophil migration and lung injury in Escherichia coli pneumonia in mice. Am. J. Pathol., 2002, 161, 2219-28.
81. Hollingsworth, J.W.; Li, Z.; Brass, D.M.; Garantziotis, S.; Timberlake, S.H.; Kim, A.; Hossain, I.; Savani, R.C.; Schwartz, D.A. CD44 regulates macrophage recruitment to the lung in lipopolysaccharide-induced airway disease. Am. J. Respir. Cell Mol. Biol., 2007, 37, 248-53.
82. Schmidt-Weber, C.B.; Blaser, K. Regulation and role of transforming growth factor-beta in immune tolerance induction and inflammation. Curr. Opin. Immunol., 2004, 16, 709-16.
83. Yu, Q.; Stamenkovic, I. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev., 1999, 13, 35-48.
84. Yu, Q.; Stamenkovic, I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev., 2000, 14, 163-76.
85. Acharya, P.S.; Majumdar, S.; Jacob, M.; Hayden, J.; Mrass, P.; Weninger, W.; Assoian, R.K.; Pure, E. Fibroblast migration is mediated by CD44-dependent TGF beta activation. J. Cell Sci., 2008, 121, 1393-402.
86. Hart, S.P.; Dougherty, G.J.; Haslett, C.; Dransfield, I. CD44 regulates phagocytosis of apoptotic neutrophil granulocytes, but not apoptotic lymphocytes, by human macrophages. J. Immunol., 1997, 159, 919-25.
87. Vachon, E.; Martin, R.; Kwok, V.; Cherepanov, V.; Chow, C.W.; Doerschuk, C.M.; Plumb, J.; Grinstein, S.; Downey, G.P. CD44-mediated phagocytosis induces inside-out activation of complement receptor-3 in murine macrophages. Blood, 2007, 110, 4492-502.
88. Liang, J.; Jiang, D.; Griffith, J.; Yu, S.; Fan, J.; Zhao, X.; Bucala, R.; Noble, P.W. CD44 is a negative regulator of acute pulmonary inflammation and lipopolysaccharide-TLR signaling in mouse macrophages. J. Immunol., 2007, 178, 2469-75.
89. Kawana, H.; Karaki, H.; Higashi, M.; Miyazaki, M.; Hilberg, F.; Kitagawa, M.; Harigaya, K. CD44 Suppresses TLR-Mediated Inflammation. J. Immunol., 2008, 180, 4235-45.
90. Krammer, P.H.; Arnold, R.; Lavrik, I.N. Life and death in peripheral T cells. Nat. Rev. Immunol., 2007, 7, 532-42.
91. McKallip, R.J.; Do, Y.; Fisher, M.T.; Robertson, J.L.; Nagarkatti, P.S.; Nagarkatti, M. Role of CD44 in activation-induced cell death: CD44-deficient mice exhibit enhanced T cell response to conventional and superantigens. Int. Immunol., 2002, 14, 1015-26.
92. Do, Y.; Rafi-Janajreh, A.Q.; McKallip, R.J.; Nagarkatti, P.S.; Nagarkatti, M. Combined deficiency in CD44 and Fas leads to exacerbation of lymphoproliferative and autoimmune disease. Int. Immunol., 2003, 15, 1327-40.
93. Ruffell, B.; Johnson, P. Hyaluronan induces cell death in activated T cells through CD44. J. Immunol., 2008, 181, 7044-54.
94. Nakano, K.; Saito, K.; Mine, S.; Matsushita, S.; Tanaka, Y. Engagement of CD44 up-regulates Fas ligand expression on T cells leading to activation-induced cell death. Apoptosis, 2007, 12, 45-54.
95. Rouschop, K.; Roelofs, J.J.; Claessen, N.; da Costa Martins, P.; Zwaginga, J.J.; Pals, S.T.; Weening, J.J.; Florquin, S. Protection against renal ischemia reperfusion injury by CD44 disruption. J. Am. Soc. Nephrol., 2005, 16, 2034-43.
96. Herrera, M.B.; Bussolati, B.; Bruno, S.; Morando, L.; Mauriello-Romanazzi, G.; Sanavio, F.; Stamenkovic, I.; Biancone, L.; Camussi, G. Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury. Kidney Int., 2007, 72, 430-41.
97. Wang, X.; Xu, L.; Wang, H.; Zhan, Y.; Pure, E.; Feuerstein, G.Z. CD44 deficiency in mice protects brain from cerebral ischemia injury. J. Neurochem., 2002, 83, 1172-9.
98. Huebener, P.; Abou-Khamis, T.; Zymek, P.; Bujak, M.; Ying, X.; Chatila, K.; Haudek, S.; Thakker, G.; Frangogiannis, N.G. CD44 is critically involved in infarct healing by regulating the inflammatory and fibrotic response. J. Immunol., 2008, 180, 2625-33.
99. Svee, K.; White, J.; Vaillant, P.; Jessurun, J.; Roongta, U.; Krumwiede, M.; Johnson, D.; Henke, C. Acute lung injury fibroblast migration and invasion of a fibrin matrix is mediated by CD44. J. Clin. Invest., 1996, 98, 1713-27.
100. Chen, D.; McKallip, R.J.; Zeytun, A.; Do, Y.; Lombard, C.; Robertson, J.L.; Mak, T.W.; Nagarkatti, P.S.; Nagarkatti, M. CD44-deficient mice exhibit enhanced hepatitis after concanavalin A injection: evidence for involvement of CD44 in activation-induced cell death. J. Immunol., 2001, 166, 5889-97.
101. McKallip, R.J.; Fisher, M.; Gunthert, U.; Szakal, A.K.; Nagarkatti, P.S.; Nagarkatti, M. Role of CD44 and its v7 isoform in staphylococcal enterotoxin B-induced toxic shock: CD44 deficiency on hepatic mononuclear cells leads to reduced activation-induced apoptosis that results in increased liver damage. Infect. Immunol., 2005, 73, 50-61.
102. Camp, R.L.; Scheynius, A.; Johansson, C.; Pure, E. CD44 is necessary for optimal contact allergic responses but is not required for normal leukocyte extravasation. J. Exp. Med., 1993, 178, 497-507.
103. Gonda, A.; Gal, I.; Szanto, S.; Sarraj, B.; Glant, T.T.; Hunyadi, J.; Mikecz, K. CD44, but not l-selectin, is critically involved in leucocyte migration into the skin in a murine model of allergic dermatitis. Exp. Dermatol., 2005, 14, 700-8.
104. Katoh, S.; Matsumoto, N.; Kawakita, K.; Tominaga, A.; Kincade, P.W.; Matsukura, S.A role for CD44 in an antigen-induced murine model of pulmonary eosinophilia. J. Clin. Invest., 2003, 111, 1563-70.
105. Mikecz, K.; Brennan, F.R.; Kim, J.H.; Glant, T.T. Anti-CD44 treatment abrogates tissue oedema and leukocyte infiltration in murine arthritis. Nat. Med., 1995, 1, 558-63.
106. Verdrengh, M.; Holmdahl, R.; Tarkowski, A. Administration of antibodies to your (CD44) delays the start and ameliorates the severity of collagen II arthritis. Scand. J. Immunol., 1995, 42, 353-8.
107. Zeidler, A.; Brauer, R.; Thoss, K.; Bahnsen, J.; Heinrichs, V.; Jablonski-Westrich, D.; Wroblewski, M.; Rebstock, S.; Hamann, A. Therapeutic effects of antibodies against adhesion molecules in murine collagen type II-induced arthritis. Autoimmunity, 1995, 21, 245-52.
108. Brennan, F.R.; O'Neill, J.K.; Allen, S.J.; Butter, C.; Nuki, G.; Baker, D. CD44 is involved in selective leucocyte extravasation during inflammatory central nervous system disease. Immunology, 1999, 98, 427-35.
109. Brocke, S.; Piercy, C.; Steinman, L.; Weissman, I.L.; Veromaa, T. Antibodies to CD44 and integrin alpha(4), but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment. Proc. Natl. Acad. Sci. USA, 1999, 96, 6896-901.
110. Xu, H.; Manivannan, A.; Liversidge, J.; Sharp, P.F.; Forrester, J.V.; Crane, I.J. Involvement of CD44 in leukocyte trafficking at the blood-retinal barrier. J. Leukoc. Biol., 2002, 72, 1133-41.
111. Weiss, L.; Slavin, S.; Reich, S.; Cohen, P.; Shuster, S.; Stern, R.; Kaganovsky, E.; Okon, E.; Rubinstein, A.M.; Naor, D. Induction of resistance to diabetes in non-obese diabetic mice by targeting CD44 with a specific monoclonal antibody. Proc. Natl. Acad. Sci. USA, 2000, 97, 285-90.
112. Nedvetzki, S.; Walmsley, M.; Alpert, E.; Williams, R.O.; Feldmann, M.; Naor, D. CD44 involvement in experimental collagen-induced arthritis (CIA). J. Autoimmun., 1999, 13, 39-47.
113. Stoop, R.; Kotani, H.; McNeish, J.D.; Otterness, I.G.; Mikecz, K. Increased resistance to collagen-induced arthritis in CD44-deficient DBA/ 1 mice. Arthritis Rheum., 2001, 44, 2922-31.
114. Stoop, R.; Gal, I.; Glant, T.T.; McNeish, J.D.; Mikecz, K. Trafficking of CD44-deficient murine lymphocytes under normal and inflammatory conditions. Eur. J. Immunol., 2002, 32, 2532-42.
115. Platt, V.M.; Szoka, F.C., Jr. Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor. Mol. Pharm., 2008, 5, 474-86.
116. Migliore, A.; Granata, M. Intra-articular use of hyaluronic acid in the treatment of osteoarthritis. Clin. Interv. Aging, 2008, 3, 365-9.
117. Balazs, E.A. Hyaluronan as an ophthalmic viscoelastic device. Curr. Pharm. Biotechnol., 2008, 9, 236-8.
118. Fedok, F.G. Advances in minimally invasive facial rejuvenation. Curr. Opin. Otolaryngol. Head Neck Surg., 2008, 16, 359-68.
119. Mummert, M.E.; Mohamadzadeh, M.; Mummert, D.I.; Mizumoto, N.; Takashima, A. Development of a peptide inhibitor of hyaluronan-mediated leukocyte trafficking. J. Exp. Med., 2000, 192, 769-79.
120. Guan, H.; Nagarkatti, P.S.; Nagarkatti, M. Blockade of hyaluronan inhibits IL-2-induced vascular leak syndrome and maintains effectiveness of IL-2 treatment for metastatic melanoma. J. Immunol., 2007, 179, 3715-23.
121. Savinov, A.Y.; Strongin, A.Y. Defining the roles of T cell membrane proteinase and CD44 in type 1 diabetes. IUBMB Life, 2007, 59, 6-13.
122. Garin, T.; Rubinstein, A.; Grigoriadis, N.; Nedvetzki, S.; Abramsky, O.; Mizrachi-Koll, R.; Hand, C.; Naor, D.; Karussis, D. CD44 variant DNA vaccination with virtual lymph node ameliorates experimental autoimmune encephalomyelitis through the induction of apoptosis. J. Neurol. Sci., 2007, 258, 17-26.
123. Hayer, S.; Steiner, G.; Gortz, B.; Reiter, E.; Tohidast-Akrad, M.; Amling, M.; Hoffmann, O.; Redlich, K.; Zwerina, J.; Skriner, K.; Hilberg, F.; Wagner, E.F.; Smolen, J.S.; Schett, G. CD44 is a determinant of inflammatory bone loss. J. Exp. Med., 2005, 201, 903-14.
124. Rafi-Janajreh, A.Q.; Chen, D.; Schmits, R.; Mak, T.W.; Grayson, R.L.; Sponenberg, D.P.; Nagarkatti, M.; Nagarkatti, P.S. Evidence for the involvement of CD44 in endothelial cell injury and induction of vascular leak syndrome by IL-2. J. Immunol., 1999, 163, 1619-27.
125. Mustafa, A.; McKallip, R.J.; Fisher, M.; Duncan, R.; Nagarkatti, P.S.; Nagarkatti, M. Regulation of interleukin-2-induced vascular leak syndrome by targeting CD44 using hyaluronic acid and anti-CD44 antibodies. J. Immunother., 2002, 25, 476-88.
126. Wittig, B.M.; Johansson, B.; Zoller, M.; Schwarzler, C.; Gunthert, U. Abrogation of experimental colitis correlates with increased apoptosis in mice deficient for CD44 variant exon 7 (CD44v7). J. Exp. Med., 2000, 191, 2053-63.
127. Wittig, B.; Schwarzler, C.; Fohr, N.; Gunthert, U.; Zoller, M. Cutting edge - curative treatment of an experimentally induced colitis by a CD44 variant v7-specific antibody. J. Immunol., 1998, 161, 1069-73.
128. Farkas, S.; Hornung, M.; Sattler, C.; Anthuber, M.; Gunthert, U.; Herfarth, H.; Schlitt, H.J.; Geissler, E.K.; Wittig, B.M. Short-term treatment with anti-CD44v7 antibody, but not CD44v4, restores the gut mucosa in established chronic dextran sulphate sodium (DSS)-induced colitis in mice. Clin. Exp. Immunol., 2005, 142, 260-7.